General
| Peptide: | KSL-W |
| Microorganism: | Candida albicans ATCC-SC5314 |
| Administration: | |
| Stage: | Preformed biofilm |
| Notes: |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| XTT assay | Not Active | 19.116 uM | |
| XTT assay | 21 - 50% | 19.116 uM | |
| XTT assay | 51 - 90% | 38.232 uM |
Reference
- Simon Theberge, Abdelhabib Semlali, Abdullah Alamri, Kai P Leung, Mahmoud Rouabhia C. albicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-W
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com